An assessment of eligibility for inhaled insulin (Exubera): the Fremantle Diabetes Study.
Davis
Timothy M E
TM
School of Medicine and Pharmacology, Fremantle Hospital, P.O. Box 480, Fremantle, WA 6959, Australia. tdavis@cyllene.uwa.edu.au
Davis
Wendy A
WA
D000280:Administration, Inhalation; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007328:Insulin / Q000008:administration & dosage* / Q000627:therapeutic use*; D008137:Longitudinal Studies; D008875:Middle Aged; D018579:Patient Selection
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin; C473734:Exubera